HomeMarket NewsEli Lilly's Tender Offer Extension for Point Biopharma Acquisition

Eli Lilly’s Tender Offer Extension for Point Biopharma Acquisition

Actionable Trade Ideas

always free

Indianapolis - April 2016: Eli Lilly and Company V

jetcityimage

Eli Lilly’s (NYSE:LLY) recent announcement of extending its tender offer to acquire Point Biopharma Global (NASDAQ:PNT) comes in the wake of opposition from a major shareholder of the latter company regarding their $1.4 billion deal.

Back in early October, LLY agreed

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.